Although further research will be required to elucidate the mechanisms that regulate Tomm34 in ovarian and other cancers, our data imply that Tomm34 has pro-tumourigenic actions and may serve as a useful prognostic indicator and potential therapeutic target in ovarian cancers. This evidence concerns the gene TOMM34 and ovarian cancer.